With approx 600-900 patients in Canada, and longer timelines for reimbursement approvals, I think 2025 numbers will be very small.
If we can get to 100-150 active patients in Canada by the end of 2026 (one third of the estimated patients @ 50% persistence), I think Acadia will be doing well.
- Forums
- ASX - By Stock
- Ann: Notification of buy-back - NEU
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.92%
!
$14.07

With approx 600-900 patients in Canada, and longer timelines for...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.07 |
Change
-0.130(0.92%) |
Mkt cap ! $1.742B |
Open | High | Low | Value | Volume |
$14.23 | $14.71 | $14.01 | $4.608M | 324.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 1692 | $14.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.08 | 523 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 702 | 14.050 |
11 | 1058 | 14.040 |
9 | 2548 | 14.030 |
5 | 691 | 14.020 |
5 | 1269 | 14.010 |
Price($) | Vol. | No. |
---|---|---|
14.060 | 1594 | 13 |
14.070 | 1703 | 11 |
14.080 | 1383 | 7 |
14.090 | 1266 | 5 |
14.100 | 1154 | 4 |
Last trade - 15.50pm 30/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |